chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Erythema, Feeling hot, Headache, Hypokinesia, Injection site oedema
Clinical narrative: From initial information received on 3/8/05 from another manufacturer (reference number WAES0501USA04558), initially reported by a nurse, regarding an adverse event, it was reported that a 30 year old male patient received his first dose of FLUZONE, lot number U1531AA, administered in the left deltoid (route of administration not reported), and his first dose of PNEUMOVAX 23, lot number 647724/0946N, administered IM in the left deltoid on 1/7/05 at 10:00 AM. Two days later, at 9:00 AM, the patient developed redness, swelling, tenderness, and pain at the site of injection, as well as, nausea, vomiting, and severe headache. The patient was seen in the emergency room that same day. Reportedly, the patient stated that it hurt to raise or move the arm. He was treated with Augmentin and IM Rocephin. On exam, the patient had a fever as well as arm redness, warmth, and swelling. On 1/10/05, per the nurse, the redness, pain, swelling and warmth at the site had increased with decreased range of motion in the arm. The patient was diagnosed with left arm cellulitis and was admitted to the hospital. Medical records indicated that the chief complaint at admission included weakness, nausea, vomiting, headache, and pain and redness in the left arm. During the hospital course, the patient was treated with IV fluids, Unasyn, Solu-Medrol, Reglan, Entex PSE, and Darvocet-N 100 as well as saline spray and amantadine hydrochloride. Influenza AB screen was presumptive negative for the influenza A or B antigen. The patient was discharged from the hospital and recovered on 1/24/05.
Age: 31.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Injection site pain, Injection site reaction, Laboratory test abnormal, Nausea, Pyrexia
Clinical narrative: From initial information received on 3/8/05 from another manufacturer (reference number WAES0501USA04558), initially reported by a nurse, regarding an adverse event, it was reported that a 30 year old male patient received his first dose of FLUZONE, lot number U1531AA, administered in the left deltoid (route of administration not reported), and his first dose of PNEUMOVAX 23, lot number 647724/0946N, administered IM in the left deltoid on 1/7/05 at 10:00 AM. Two days later, at 9:00 AM, the patient developed redness, swelling, tenderness, and pain at the site of injection, as well as, nausea, vomiting, and severe headache. The patient was seen in the emergency room that same day. Reportedly, the patient stated that it hurt to raise or move the arm. He was treated with Augmentin and IM Rocephin. On exam, the patient had a fever as well as arm redness, warmth, and swelling. On 1/10/05, per the nurse, the redness, pain, swelling and warmth at the site had increased with decreased range of motion in the arm. The patient was diagnosed with left arm cellulitis and was admitted to the hospital. Medical records indicated that the chief complaint at admission included weakness, nausea, vomiting, headache, and pain and redness in the left arm. During the hospital course, the patient was treated with IV fluids, Unasyn, Solu-Medrol, Reglan, Entex PSE, and Darvocet-N 100 as well as saline spray and amantadine hydrochloride. Influenza AB screen was presumptive negative for the influenza A or B antigen. The patient was discharged from the hospital and recovered on 1/24/05.
Age: 31.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Red blood cell abnormality, Tenderness, Urine analysis abnormal, Vomiting, White blood cell count increased
Clinical narrative: From initial information received on 3/8/05 from another manufacturer (reference number WAES0501USA04558), initially reported by a nurse, regarding an adverse event, it was reported that a 30 year old male patient received his first dose of FLUZONE, lot number U1531AA, administered in the left deltoid (route of administration not reported), and his first dose of PNEUMOVAX 23, lot number 647724/0946N, administered IM in the left deltoid on 1/7/05 at 10:00 AM. Two days later, at 9:00 AM, the patient developed redness, swelling, tenderness, and pain at the site of injection, as well as, nausea, vomiting, and severe headache. The patient was seen in the emergency room that same day. Reportedly, the patient stated that it hurt to raise or move the arm. He was treated with Augmentin and IM Rocephin. On exam, the patient had a fever as well as arm redness, warmth, and swelling. On 1/10/05, per the nurse, the redness, pain, swelling and warmth at the site had increased with decreased range of motion in the arm. The patient was diagnosed with left arm cellulitis and was admitted to the hospital. Medical records indicated that the chief complaint at admission included weakness, nausea, vomiting, headache, and pain and redness in the left arm. During the hospital course, the patient was treated with IV fluids, Unasyn, Solu-Medrol, Reglan, Entex PSE, and Darvocet-N 100 as well as saline spray and amantadine hydrochloride. Influenza AB screen was presumptive negative for the influenza A or B antigen. The patient was discharged from the hospital and recovered on 1/24/05.
Age: 31.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: White blood cell disorder
Clinical narrative: From initial information received on 3/8/05 from another manufacturer (reference number WAES0501USA04558), initially reported by a nurse, regarding an adverse event, it was reported that a 30 year old male patient received his first dose of FLUZONE, lot number U1531AA, administered in the left deltoid (route of administration not reported), and his first dose of PNEUMOVAX 23, lot number 647724/0946N, administered IM in the left deltoid on 1/7/05 at 10:00 AM. Two days later, at 9:00 AM, the patient developed redness, swelling, tenderness, and pain at the site of injection, as well as, nausea, vomiting, and severe headache. The patient was seen in the emergency room that same day. Reportedly, the patient stated that it hurt to raise or move the arm. He was treated with Augmentin and IM Rocephin. On exam, the patient had a fever as well as arm redness, warmth, and swelling. On 1/10/05, per the nurse, the redness, pain, swelling and warmth at the site had increased with decreased range of motion in the arm. The patient was diagnosed with left arm cellulitis and was admitted to the hospital. Medical records indicated that the chief complaint at admission included weakness, nausea, vomiting, headache, and pain and redness in the left arm. During the hospital course, the patient was treated with IV fluids, Unasyn, Solu-Medrol, Reglan, Entex PSE, and Darvocet-N 100 as well as saline spray and amantadine hydrochloride. Influenza AB screen was presumptive negative for the influenza A or B antigen. The patient was discharged from the hospital and recovered on 1/24/05.
Age: 0.34
Sex: M
Vaccine: IPV
Symptoms: Autism
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE333114FEB05), initially reported by the patient's parent, regarding an adverse event occurring in the USA, it was reported that a 17 month old male patient received a dose of IPOL on 3/5/02. The lot number, route and site of administration were not reported. Approximately 12 months later, in April of 2003, the patient developed autism. He had previously received a dose of IPOL on 12/31/01. No other information was provided at this time. It is unknown whether the patient recovered from this event. (OMIC)
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Unevaluable event
Clinical narrative: Death within 24 hours after admission of vaccination.
Age: 0.11
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Bradycardia, Hypoxia, Irritability, Laboratory test abnormal, Livedo reticularis
Clinical narrative: Desturations, mottled skin, bradycardia, irritability. All this occurred about 8-9 hours after Pediarix/HIB/Prevnar administration. Child had to be placed on O2, CR monitor and pulse oximetry for 2 days. Vaccine given while in hospital (prematurity).
Age: 0.11
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Bradycardia, Hypoxia, Irritability, Pyrexia
Clinical narrative: Desaturation, bradycardia within 8-9 hours after vaccines. Irritability began at approximately 3 hours after vaccines. No interventions required. Temperature slightly elevated. Infant placed on pulse oximetry. Continued monitoring.
Age: 1.31
Sex: F
Vaccine: HIBV, MMR, PNC
Symptoms: Injection site erythema
Clinical narrative: Erythema at site of injection about 2 inches across.
Age: 1.16
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Varivax given on 12/03/2002. Chicken pox dx 03/09/2005.
Age: 19.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Headache, Nasal congestion, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: PM following IZ, pt developed sore throat, HA, fever and chills. Seen back in Health Center next day . Pt had fever of 102 degrees F, b/p-140/80,P-112. Nasal congestion, throat injected zero exudates, lungs clear, heart SI SIIreg rr. Rapid strep(-),Tx with ibuprofen, rest, fluids and to follow up in 24hours.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Urticaria
Clinical narrative: Parent reporting that arm that MMR vaccine administeed in, is red approximately 2 x 4" around injection site with a wheal approximately 1" in diameter.?Tender to touch.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Hypotonia, Injection site erythema, Injection site swelling
Clinical narrative: Swollen, tense, and red right upper arm, around injection site. This occurred 72 hours after vaccination and resolved in 3 days.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV
Symptoms: Injection site erythema, Injection site swelling, Tension
Clinical narrative: Swollen, tense and red right upper arm, around injection site. This occurred 72 hours after vaccination and resolved in 3 days.
Age: 43.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Rash
Clinical narrative: On 12/24/04, vaccine administered and 2 weeks later rash under left breast, which subsided after 1 week. Rash was itchy and brown. On 01/24/05, dose 2 administered, rash presented 3 weeks later, itchy and brown. Rash is still present. No treatment sought for this but patient will make appointment for next week.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Crying, Erythema, Urticaria
Clinical narrative: Mom called left health department at 3:30 pm, states child was fine. Driving home, child started to cry, then threw up in car. Mom states child became red, broke out in hives and she called to health department. Instructed to go to the emergency room for evaluation of the adverse reaction. Per mom patient was given a shot of epinephrine and liquid Benadryl, observed for 3 hours and sent home with Benadryl every 6 hours. Next day resting at home.
Age: 5.0
Sex: M
Vaccine: UNK
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at immunization site.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Urticaria
Clinical narrative: 5 min after administering DTaP, IPV and MMR, Pt. developed hive above site of MMR.  Pt given Benadryl per Emergency treatment protocol and sent to Pediatrician from health department.
Age: 6.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: L-3"xW-3" area rt deltoid-warm, red, hardened area, mom took to er where they gave her antibotics/steroids.
Age: 5.0
Sex: F
Vaccine: DTP, IPV
Symptoms: Medication error
Clinical narrative: I took my daughter to have her shots done for school on arrival they gave me the paper work for dtp, polio,and mmr. That is what she was supposed to receive.They gave me my paperwork to take to school and I looked it over when i got hon and noticed that they had the days date located on pneumonia conj and not mmr so i called them immediately to see what had happened this had all occured on 3/17/05. well they put me through to the nurse and she put me on hold a minute then came back got my phone number and said it would take a minute to figure out what she had done,then she would call me back. About 45 mins. later she returned the call and said that she had actually received the mmr and not the pneumonia shot and that she had entered in the wrong code and that she had to wait till this morning to change when the supervisor was in. Then someone called this morning and said that she got the pneumonia shot and not the mmr.So after they have gave me two or three different stories I am not sure and really think they are not sure what they actually gave her. I need something done but cannot keep torchering myself nor my daughter. After reading this you can understand why i cannot answer number thirteen fully.
Age: 0.56
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying, Pain, Pyrexia, Respiratory rate increased
Clinical narrative: 9:00 p.m. 3/14/05 patient's temp (axillary) digital thermometer 104.  Mom gave her son infant Tylenol - temp down to 102 (axillary). Infant moaning apparent pain and crying went to ER - breathing rapid. ER doctor gave infant pedialite and observed for three hours. Fever 98 when left ER 3/14/05. 3/15/05 temp okay.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site induration, Pruritus, Rash
Clinical narrative: Two days after immunization patient complained of itching and burning of right deltoid area. Had induration of 20mm (2.5cm) with red rash.
Age: 18.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Headache
Clinical narrative: Received hep B vaccine at 1530 on 3/1/05.  Upon arising 3/2/05 c/o faintness & headache unrelieved by Tylenol.  Persisted throughout that day.  On 3/3/05 she was much improved.  Dr. was not contacted by mother for symptoms.  Was afebrile.
Age: 19.0
Sex: M
Vaccine: TD
Symptoms: Feeling hot, Muscle spasms, Musculoskeletal stiffness, Pain, Pyrexia
Clinical narrative: At about 11 p.m. on March 7, 2005, my muscles started spasming and were hot. It covered my entire body. My body was aching all over. I was shaking uncontrollably. I was unable to sleep at all during the entire night. By afternoon the spasms had subsided. The morning of March 8 my temperature was 102 F. During the day my fever dropped to a low grade fever. This continued through March 9. When I woke up on March 10, my fever was gone, but my neck was stiff. I applied heat and it felt better.
Age: 19.0
Sex: M
Vaccine: TD
Symptoms: Sleep disorder, Tremor
Clinical narrative: At about 11 p.m. on March 7, 2005, my muscles started spasming and were hot. It covered my entire body. My body was aching all over. I was shaking uncontrollably. I was unable to sleep at all during the entire night. By afternoon the spasms had subsided. The morning of March 8 my temperature was 102 F. During the day my fever dropped to a low grade fever. This continued through March 9. When I woke up on March 10, my fever was gone, but my neck was stiff. I applied heat and it felt better.
Age: 4.0
Sex: M
Vaccine: PNC
Symptoms: Feeling hot, Swelling
Clinical narrative: Arm swollen, tight, warm. Mom notice 03/12/2005. States child not complaining about it. States better today.
Age: 6.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Flushing, Gait disturbance, Headache, Injection site mass, Lethargy
Clinical narrative: This is a 5 year old girl who had received no vaccinations in the past except for 1 DTaP vaccine at 11 months without significant adverse effects who agreed to vaccination as discussed with the doctor on 3/15/05. In her right thigh she was given IPV and MMR.  In her left thigh she was given DTaP. 2 days after vaccination her mother phoned me reporting that patient had a 105 degree temp which was not responding to Motrin 1 and a half teaspoons and that she had a large painful lump on her thigh and headache and lethargy.  I asked her to bring the patient in ASAP, where she was immediately given 1 and a half teaspoons of Tylenol and 25 mg of Benadryl.  On exam she was lethargic, flushed, and had a >5 cm tender, firm lump on her left thigh.  She walked with a limp.  Her exam was otherwise normal.  AFter 20 minutes of observation after the tylenol and benadryl she became more awake and alert, less flushed, and her temperature reduced to 100.8.  I sent her home with instructions for the mom to give her tylenol and benadryl as above every 6 hours until her symptoms resolved.  I told her to give a lukewarm bath for fever >104 and call me.
Age: 6.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This is a 5 year old girl who had received no vaccinations in the past except for 1 DTaP vaccine at 11 months without significant adverse effects who agreed to vaccination as discussed with the doctor on 3/15/05. In her right thigh she was given IPV and MMR.  In her left thigh she was given DTaP. 2 days after vaccination her mother phoned me reporting that patient had a 105 degree temp which was not responding to Motrin 1 and a half teaspoons and that she had a large painful lump on her thigh and headache and lethargy.  I asked her to bring the patient in ASAP, where she was immediately given 1 and a half teaspoons of Tylenol and 25 mg of Benadryl.  On exam she was lethargic, flushed, and had a >5 cm tender, firm lump on her left thigh.  She walked with a limp.  Her exam was otherwise normal.  AFter 20 minutes of observation after the tylenol and benadryl she became more awake and alert, less flushed, and her temperature reduced to 100.8.  I sent her home with instructions for the mom to give her tylenol and benadryl as above every 6 hours until her symptoms resolved.  I told her to give a lukewarm bath for fever >104 and call me.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, Swelling, Warm to touch.  Patient started on Keflex 250ml/5mg 3ml q8h x7days. Follow up report received on 04/28/2005:  Reaction on left arm.
Age: 43.0
Sex: F
Vaccine: HEP
Symptoms: Arthralgia, Joint stiffness, Musculoskeletal stiffness, Pain, Pyrexia
Clinical narrative: She complained of arm and shoulder pain and stiffness on day vaccine was given. The following morning she woke up with chills, fever (101.9), and joint pain and stiffness which worsened throughout the day. She took Excedrin and Motrin which relieved some of the pain and fever. She took Nyquil at bedtime. On day 2 she continued to have fever(100.9) and body ache but the joint pain and stiffness was improved. On day 3 the fever subsided.
Age: 43.0
Sex: F
Vaccine: HEP
Symptoms: Shoulder pain
Clinical narrative: She complained of arm and shoulder pain and stiffness on day vaccine was given. The following morning she woke up with chills, fever (101.9), and joint pain and stiffness which worsened throughout the day. She took Excedrin and Motrin which relieved some of the pain and fever. She took Nyquil at bedtime. On day 2 she continued to have fever(100.9) and body ache but the joint pain and stiffness was improved. On day 3 the fever subsided.
Age: 54.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Neck pain, Oedema peripheral
Clinical narrative: On 02/24/05, aching in wrist, knees, right shoulder and neck. On 03/03/05, went to emergency room, Medrol dose pack ordered. After 1st does felt a little relief, gets better each day. Day after medication was finished, swelling in hands and joint pain returned. Joint pain much better but swelling is still there.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Pruritus, Swelling
Clinical narrative: Parents noticed a 50 cent size red area on left arm on 03/15/05. Now on 03/16/05, redness, warmth, swelling and itching from shoulder to left elbow.
Age: 1.78
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Onset today, hard erythematous warm area surrounding both immunizations sites. Left leg redness measures approximately 3" across and right leg redness measures approximately 1" across.
Age: 1.5
Sex: F
Vaccine: DTAP, IPV, PNC
Symptoms: Dysphonia, Erythema, Insomnia, Irritability, Oedema
Clinical narrative: Very cranky all evening, awake most of night, in AM had facial hives, swollen nose, raspy voice, hives spread all day, saw PMD at 17:00 on 3/9/05 with rash all over, that night had marked redness, swelling of left leg. Treated with Benadryl after seeing PMD. Rash better on Thursday. Friday had rash on face only. Symptoms cleared by Monday. Pt was adopted and has an unk vaccination history. All information is from parent.
Age: 1.5
Sex: F
Vaccine: DTAP, IPV, PNC
Symptoms: Rash, Urticaria
Clinical narrative: Very cranky all evening, awake most of night, in AM had facial hives, swollen nose, raspy voice, hives spread all day, saw PMD at 17:00 on 3/9/05 with rash all over, that night had marked redness, swelling of left leg. Treated with Benadryl after seeing PMD. Rash better on Thursday. Friday had rash on face only. Symptoms cleared by Monday. Pt was adopted and has an unk vaccination history. All information is from parent.
Sex: M
Vaccine: DTAP, PNC
Symptoms: Anger, Erythema, Rash macular
Clinical narrative: From initial information received on 06Feb04 from another manf (control number HQWYE898410NOV03), initially reported by a physician, regarding an adverse event occurring, it was reported that a male pt (age not reported), received a dose of IPOL, lot number not reported, route and site of admin not reported, on 14Nov03. An unspecified time later on that same day, the pt developed some red areas on his head. Reportedly, th event subsided spontaneously without treatment, but the pt's recovery status in unk. From additional information received on 05Oct04 from a health care professional, it was reported that the pt was very behind on his vaccinations and received his vaccines in two separate office visits. The pt received the IPOL vaccination on 07Nov03 not 14Nov03 as previously reported by another manf. Following the administration of the IPOL vaccine, the pt became very angry and turned red for a few minutes as a results, but he did not have an adverse event. The pt did have an adverse event after receiving a Dtap (Daptacel) vaccination, lot number C1606AA, administered in the right thigh, the pt also received a Prevnar vaccination, lot number 493475, admin in the left thigh at 11:15AM on 07Nov04. Reportedly within 60 seconds of administration the pt developed blotchy redness on his face and neck. A 1/2 tsp. of Zyrtec was provided as treatment and the pt was kept in the physician's office. The pt recovered from the event, all redness resolved, the pt had no temp and was acting normal.
Age: 1.26
Sex: M
Vaccine: DTAP, PNC
Symptoms: Difficulty in walking, Hypersensitivity
Clinical narrative: Walking difficulty, from initial information received on 02/13/2004 from another manufacturer,(control number HQWYE583127JAN04), initially reported by a physician, regarding an adverse event occurring in the USA, it was reported that a 15 month old male patient received  a dose of DAPTACEL, lot number C1612AA, route and site of administration not reported, on 01/22/2004. An unspecified time later on that same day, the patient "did not want to walk" Reportedly, the patient recovered from this event. From additional information received on 04/22/2004 from a health care professional, the patient's address and telephone number as well ad the date of birth were provided. Facility address and telephone number as well as the vaccine administrator and responsible physician information were also provided. It was reported that the patient has no siblings. His birth weight was 9 pounds and 11 ounces. Reportedly, the child has an allergy to amoxicillin, It was also reported that DAPTACEL was administered in the left upper anterolateral thigh and the dose administered was his 4th dose. On the same day, the child also received PREVNAR, lot number 493-540, manufacturer Wyeth(Lederle) administered in the left lower anterolateral thigh and as well as his third dose of COMVAX, lot number 0753M, manufacturer Merck, administered in the right anterolateral thigh. The vaccines were administered at a private doctor's office/hospital and purchased with private funds. No further information is anticipated this case is considered closed.
Age: 1.79
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: From initial information received on 05/24/2004 from a registered nurse regarding an adverse event occurring in the USA, it was reported that a 22 month old female patient received a dose of IPOL, lot number X0772, with an expiration date of July 2006, administered subcutaneously in an unspecified site on 05/20/2004. That same day, the patients left thigh became red, swollen, and hot. The reaction was non-tender. The child also developed erythema which was not intense. Concomitant medications at the time of vaccination included Tylenol. The child received her first does of IPOL, lot number W0063, with an expiration date of October 2005, on 10/07/2002 and did not experience any reactions. The patient's recovery status was not reported. From additional information received on 05/26/2004 from a registered nurse, the patient's full name, address and telephone number as well as her date of birth were provided. The patient's birth weight was reported as nine pounds and six ounces. The reporter also provided the names of the vaccine administrator and the responsible physician. Per the reporter, IPOL was administered subcutaneously in the right thigh. In addition to IPOL, the patient also received her fourth dose of DAPTACEL, lot number C1614AA, administered intra muscularly in the right thigh. She was vaccinated at a private doctor's office/hospital in the county on 05/20/2004 at 10:00 am and developed a reaction  on the following day. Reportedly, the vaccines were purchased with private funds. The patient previously received 2 doses of IPOL. She did not have any illnesses at the time of vaccination. Per the reporter, the patient recovered from these events. Note: The adverse events occurred in the left thigh however it was not mentioned what vaccinations were administered in the left thigh. The products mentioned DAPTACEL, and IPOL were both administered in the right thigh. The reporter of this case is the same reporter of cases 2004-01998 and 2004-02020.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site warmth, Oedema peripheral, Tenderness
Clinical narrative: From initial information received on 07/08/2004 from a registered nurse regarding an adverse event occurring in the USA it was reported that a five year old male patient received his 5th dose of Daptacel, lot number C1614AA  administered in the left thigh his fourth dose of IPOL, lot number X0772, administered sub-q in the left thigh, his 2nd MMR lot number 0956N (manuf. MERCK) and administered sub q in the right thigh on 05/25/2004. Later that same day the patient's left lef reportedly became swollen and was hot, red, and tender to the touch. The left thigh measured 34cm compared to the right leg at 30cm. The patinet recovered from these events. Per reporter this case had been submitted to VAERS. The reporter of this case is the same reporter of cases 200402304, 200402305, 200402306, 200402307, 200402308, 200402309, 200402310, 200402311, 200402312, and 200402322. From additional information received on 08/23/2004 from a health professional, it was reported , "Reviewed no additonal comments" No further informtaion is anticipated. this case is considered closed.
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Body temperature increased, Chills, Dehydration, Delirium
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Drug toxicity, Eye irritation, Feeling hot, Headache, Hot flush
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Immune system disorder, Lethargy, Malaise, Medication error, Mydriasis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Nervous system disorder, Neurotoxicity, Pain, Personality disorder, Pharyngolaryngeal pain
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Psychomotor hyperactivity, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Dehydration, Delirium, Drug toxicity, Eye irritation
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Headache, Immune system disorder, Lethargy, Malaise, Mydriasis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Neurological symptom, Personality disorder, Pharyngolaryngeal pain, Psychomotor hyperactivity, Pupillary reflex impaired
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Congenital brain damage, Dehydration, Derealisation, Drug toxicity
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Eye irritation, Headache, Immune system disorder, Laryngitis, Lethargy
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Malaise, Mydriasis, Nervous system disorder, Pain, Personality disorder
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Pharyngolaryngeal pain, Psychomotor hyperactivity, Pupillary reflex impaired, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Congenital brain damage, Drug toxicity, Eye irritation, Headache
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Hypothermia, Immune system disorder, Laryngitis, Lethargy, Malaise
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Mydriasis, Nervous system disorder, Neurotoxicity, Personality disorder, Pharyngitis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Psychomotor hyperactivity, Pupillary reflex impaired, Pyrexia, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference # HQWYE906427JAN05), regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptom, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Dehydration, Drug toxicity, Eye irritation, Feeling abnormal, Headache
Clinical narrative: This report was received from manf and was assigned manf report number HQWYE866626JAN05 concerning a female pt who on 12May04 was vaccinated with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live  (+) rubella virus vaccine live (RA 27/3). Concomitant therapy included a dose of varicella virus vaccine live. Subsequently, in 2004, the pt developed dehydration, malaise, personality change, lethargy, metal poisoning, neurotoxicity, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, feeling abnormal, adverse event NOS and a medication error. The pt's outcome was unk. Dehydration, malaise, personality change, lethargy, metal poisoning, neurotoxicity, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, feeling abnormal and adverse event NOS were considered other important medical events.  (OMIC) This was originally reported by a female reporter. Additional information has been requested.